세계의 혈소판 응집 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 용도별, 지역별, 전망 및 예측(2023-2030년)
Global Platelet Aggregation Devices Market Size, Share & Trends Analysis Report By Product (Consumables & Accessories, and Systems & Instruments), By End-Use, By Application (Research, and Clinical), By Regional Outlook and Forecast, 2023 - 2030
상품코드:1432722
리서치사:KBV Research
발행일:2024년 02월
페이지 정보:영문 191 Pages
라이선스 & 가격 (부가세 별도)
한글목차
혈소판 응집 장치 시장 규모는 2030년까지 11억 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 5.5%의 시장 성장률을 나타낼 전망입니다.
또한, 팬데믹 초기에는 전 세계 공급망의 광범위한 혼란이 이러한 기기의 생산과 유통에 영향을 미쳤습니다. 봉쇄, 제한 및 물류 문제로 인해 제조 공정이 지연되어 이러한 중요한 의료기기의 가용성에 영향을 미쳤습니다. 또한, 팬데믹은 원격 의료 및 원격 의료 모니터링의 보급을 가속화했습니다. 원격으로 사용하거나 원격 의료 플랫폼과 통합되는 이러한 기기들이 주목을 받았습니다. 따라서 코로나19 사태는 시장에 적당한 영향을 미쳤다고 볼 수 있습니다.
그러나 이러한 기기에는 기기 본체 구매를 포함해 많은 초기 투자비용이 소요되는 경우가 많습니다. 이러한 초기 비용은 특히 한정된 재원으로 운영되는 의료기관의 예산을 압박할 수 있습니다. 또한 혈소판 응집 검사에는 시약, 검사 키트 등 소모품이 필수적입니다. 이러한 소모품 구매와 관련된 경상비용은 전체 기기 비용의 일부가 될 수 있습니다. 따라서 이러한 요인들은 시장 성장을 제한하는 요인으로 작용할 수 있습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요약
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장이 해결해야 할 과제
Porter의 Five Forces 분석
제4장 세계 시장 : 제품별
세계의 소모품 및 부속품 시장 : 지역별
세계의 시스템 및 기기 시장 : 지역별
제5장 세계 시장 : 최종 용도별
세계의 연구 및 학술기관 시장 : 지역별
세계의 병원 시장 : 지역별
세계의 진단센터 시장 : 지역별
제6장 세계 시장 : 용도별
세계의 연구 시장 : 지역별
세계의 임상 시장 : 지역별
제7장 세계 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카/중동 및 아프리카
라틴아메리카/중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카/중동 및 아프리카
제8장 기업 개요
AggreDyne, Inc
Bio/Data Corporation
Chrono-log Corporation
Sienco, Inc
Haemonetics Corporation
F Hoffmann-La Roche Ltd.
Siemens Healthineers AG(Siemens AG)
Werfen, SA
Sysmex Corporation
제9장 혈소판 응집 기기 시장을 위한 성공 필수 조건
LSH
영문 목차
영문목차
The Global Platelet Aggregation Devices Market size is expected to reach $1.1 billion by 2030, rising at a market growth of 5.5% CAGR during the forecast period.
The Asia Pacific region witnessed a steady rise in healthcare expenditure, reflecting growing investments in healthcare infrastructure, technological advancements, and the adoption of advanced medical devices, including these devices. Consequently, the Asia Pacific region would acquire nearly 25% of the total market share by 2030. The region faced an increasing prevalence of platelet-related disorders and cardiovascular diseases. As awareness about these conditions grew, there was a heightened focus on the importance of platelet function analysis for accurate diagnostics and treatment planning. Hence, the segment will expand rapidly in the upcoming years.
Worldwide, cardiovascular diseases, such as atherosclerosis and coronary artery disease (CAD), are the primary causes of morbidity and mortality. Platelet aggregation assays are critical in evaluating platelet function, which is a fundamental component in the pathogenesis of cardiovascular disorders. In addition, the information obtained from these devices is instrumental in tailoring antiplatelet therapy. Different individuals may exhibit varying responses to antiplatelet medications. Thus, these factors will assist in the growth of the market. Additionally, Personalized medicine involves tailoring medical decisions and treatments to the individual characteristics of each patient. These devices enable clinicians to perform individualized assessments of platelet function, considering factors such as responsiveness to stimuli and variations in platelet activity. In addition, personalized antiplatelet therapy minimizes the risk of adverse reactions by avoiding unnecessary exposure to medications that may be less effective or associated with a higher risk of side effects. Thus, these factors will result in enhanced growth in the market.
Moreover, In the initial phases of the pandemic, widespread disruptions in global supply chains impacted the production and distribution of these devices. Lockdowns, restrictions, and logistical challenges led to delays in manufacturing processes, affecting the availability of these critical medical devices. Additionally, the pandemic accelerated the adoption of telemedicine and remote healthcare monitoring. These devices that could be utilized remotely or integrated with telemedical platforms gained prominence. Therefore, the COVID-19 pandemic moderately impacted the market.
However, these devices often come with a substantial initial investment, including the purchase of the equipment itself. This upfront cost can strain the budgets of healthcare facilities, especially those operating with limited financial resources. Furthermore, consumables, such as reagents and test kits, are essential for platelet aggregation tests. The recurring expenses associated with purchasing these consumables contribute to the device's overall cost. Thus, these factors will limit the growth of the market.
By Product Analysis
Based on product, the market is segmented into systems & instruments and consumables & accessories. The systems and instruments segment held a significant revenue share in the market in 2022. Ongoing technological advancements in these devices have led to the development of sophisticated systems and instruments. These advancements include improved sensors, automation, and integration with digital platforms, enhancing the overall performance of platelet aggregation assessments. Therefore, these factors will help in the growth of the segment.
By End-Use Analysis
Based on end-use, the market is divided into hospital, diagnostic centers, and research & academic institutes. In 2022, the hospital segment witnessed a substantial revenue share in the market. Hospitals heavily rely on these devices for clinical diagnostics and monitoring of patients. These devices provide critical insights into platelet function, aiding in diagnosing and managing various hematological conditions and cardiovascular diseases. The ability to perform precise and timely platelet function assessments is integral to the overall healthcare delivery within hospital environments. Thus, these factors will pose lucrative growth prospects for the segment.
By Application Analysis
On the basis of application, the market is divided into clinical and research. The clinical applications segment recorded a considerable revenue share in the market in 2022. Ongoing advancements in diagnostic technologies related to platelet function have fueled the demand for these devices in clinical settings. The devices play a crucial role in assessing platelet function, aiding in diagnosing and managing various hematological disorders and cardiovascular conditions. Therefore, these factors will boost the demand in the segment.
By Regional Analysis
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America boasts a robust and advanced healthcare infrastructure, with well-established medical facilities and research institutions. The availability of state-of-the-art healthcare facilities created a conducive environment for adopting cutting-edge medical technologies, including these devices. Therefore, these factors will pose lucrative growth prospects for the segment.
List of Key Companies Profiled
AggreDyne, Inc.
Bio/Data Corporation
Chrono-log Corporation
F. Hoffmann-La Roche Ltd.
Haemonetics Corporation
Siemens Healthineers AG (Siemens AG)
Werfen, S.A.
Sysmex Corporation
Sienco, Inc.
Global Platelet Aggregation Devices Market Report Segmentation
By Product
Consumables & Accessories
Systems & Instruments
By End-Use
Research & Academic Institutes
Hospital
Diagnostic Centers
By Application
Research
Clinical
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Platelet Aggregation Devices Market, by Product
1.4.2 Global Platelet Aggregation Devices Market, by End-Use
1.4.3 Global Platelet Aggregation Devices Market, by Application
1.4.4 Global Platelet Aggregation Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter's Five Forces Analysis
Chapter 4. Global Platelet Aggregation Devices Market by Product
4.1 Global Consumables & Accessories Market by Region
4.2 Global Systems & Instruments Market by Region
Chapter 5. Global Platelet Aggregation Devices Market by End-Use
5.1 Global Research & Academic Institutes Market by Region
5.2 Global Hospital Market by Region
5.3 Global Diagnostic Centers Market by Region
Chapter 6. Global Platelet Aggregation Devices Market by Application
6.1 Global Research Market by Region
6.2 Global Clinical Market by Region
Chapter 7. Global Platelet Aggregation Devices Market by Region
7.1 North America Platelet Aggregation Devices Market
7.1.1 North America Platelet Aggregation Devices Market by Product
7.1.1.1 North America Consumables & Accessories Market by Region
7.1.1.2 North America Systems & Instruments Market by Region
7.1.2 North America Platelet Aggregation Devices Market by End-Use
7.1.2.1 North America Research & Academic Institutes Market by Country
7.1.2.2 North America Hospital Market by Country
7.1.2.3 North America Diagnostic Centers Market by Country
7.1.3 North America Platelet Aggregation Devices Market by Application
7.1.3.1 North America Research Market by Country
7.1.3.2 North America Clinical Market by Country
7.1.4 North America Platelet Aggregation Devices Market by Country
7.1.4.1 US Platelet Aggregation Devices Market
7.1.4.1.1 US Platelet Aggregation Devices Market by Product
7.1.4.1.2 US Platelet Aggregation Devices Market by End-Use
7.1.4.1.3 US Platelet Aggregation Devices Market by Application
